New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality

References

• Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17(7):491–511. doi: 10.2165/00023210-200317070-00003
   PubMed Web of Science ®Google Scholar
• Erten E. Acute and maintenance treatment of bipolar depression. NöroPsikiyatr Arş. 2021;58(Suppl 1):S31–S40. doi: 10.29399/npa.27408
   Google Scholar
• Baek JH, Eisner LR, Nierenberg AA. Smoking and suicidality in subjects with bipolar disorder: results from the national epidemiologic survey on alcohol and related conditions (NESARC). Depress Anxiety. 2013;30(10):982–990. doi: 10.1002/da.22107 Epub 2013 May 8.
   PubMed Web of Science ®Google Scholar
• Lengvenyte A, Aouizerate B, Aubin V, et al. FondaMental Advanced Centers of expertise in bipolar disorders (FACE-BD) Collaborators; courtet P, olié E. Violent suicide attempt history in elderly patients with bipolar disorder: the role of sex, abdominal obesity, and verbal memory: results from the FACE-BD cohort (FondaMental Advanced center of expertise for bipolar disorders). J Affect Disord. 2022;296:265–276. doi: 10.1016/j.jad.2021.09.097 Epub 2021 Oct 1.
   PubMed Web of Science ®Google Scholar
• Ainiyet B, Rybakowski JK. Suicidal behaviour and lipid levels in unipolar and bipolar depression. Acta Neuropsychiatr. 2014;26(5):315–320. doi: 10.1017/neu.2014.18 Epub 2014 Jul 30.
   PubMed Web of Science ®Google Scholar
• Sani G, Perugi G, Tondo L. Treatment of bipolar disorder in a lifetime perspective: is lithium still the best choice? Clin Drug Investig. 2017;37(8):713–727. doi: 10.1007/s40261-017-0531-2
   PubMed Web of Science ®Google Scholar
• Di Vincenzo M, Luciano M, Collacchi B, et al. The predictive role of proinflammatory and neuroendocrine factors in the acute phases of bipolar disorder: study protocol of a longitudinal controlled trial. Riv Psichiatr. 2023;58(6):293–301.
   PubMed Web of Science ®Google Scholar
• Hughes JH, Dunne F, Young AH. Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium. Br J Psychiatry. 2000;177(5):447–451. doi: 10.1192/bjp.177.5.447
   PubMedGoogle Scholar
• Siwek M, Sowa-Kućma M, Styczeń K, et al. Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder. Mol Neurobiol. 2017;54(8):5883–5893. doi: 10.1007/s12035-016-0124-8 Epub 2016 Sep 23.
   PubMed Web of Science ®Google Scholar
• Sani G, Kotzalidis GD, Fiaschè F, et al. Second messengers and their importance for novel drug treatments of patients with bipolar disorder. Int Rev Psychiatry. 2022;34(7–8):736–752. doi: 10.1080/09540261.2022.2119073 Epub 2022 Sep 5.
   PubMed Web of Science ®Google Scholar
• Kishi T, Ikuta T, Matsuda Y, et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry. 2021;26(8):4146–4157. doi: 10.1038/s41380-020-00946-6 Epub 2020 Nov 11.
   PubMed Web of Science ®Google Scholar
• Kishi T, Ikuta T, Matsuda Y, et al. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Mol Psychiatry. 2022;27(2):1136–1144. doi: 10.1038/s41380-021-01334-4 Epub 2021 Oct 12.
   PubMed Web of Science ®Google Scholar
• Bahji A, Ermacora D, Stephenson C, et al. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis. J Affect Disord. 2020;269:154–184. doi: 10.1016/j.jad.2020.03.030 Epub 2020 Mar 20.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Siafis S, Mavridis D, et al. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(9):693–705. doi: 10.1016/S2215-0366(23)00199-2
   PubMed Web of Science ®Google Scholar
• VandenBos GR, editor. APA dictionary of psychology®. 2nd. (WA) DC: American Psychological Association; 2015.
   Google Scholar
• Sani G, Tondo L, Koukopoulos A, et al. Suicide in a large population of former psychiatric inpatients. Psychiatry Clin Neurosci. 2011;65(3):286–295.
   PubMed Web of Science ®Google Scholar
• Shneidman ES. Suicide as psychache. J Nerv Ment Dis. 1993;181(3):145–147. doi: 10.1097/00005053-199303000-00001
   PubMed Web of Science ®Google Scholar
• Verhofstadt M, Thienpont L, Peters GY. When unbearable suffering incites psychiatric patients to request euthanasia: qualitative study. Br J Psychiatry. 2017;211(4):238–245. doi: 10.1192/bjp.bp.117.199331
   PubMed Web of Science ®Google Scholar
• Galynker I. Conducting short-term risk assessment interviews. In: Galynker I, editor. The suicidal crisis: clinical Guide to the assessment of imminent suicide risk. (NY): Oxford University Press; 2017. p. 221–259. doi: 10.1093/med/9780190260859.001.0001
   Google Scholar
• Galynker I. The narrative-crisis model of suicide. In: Galynker I, editor. The suicidal crisis: clinical Guide to the assessment of imminent suicide risk. 2nd. (NY): Oxford University Press; 2023. p. 62–C3P119. doi: 10.1093/med/9780197582718.001.0001
   Google Scholar
• Galynker I. The suicide crisis syndrome. In: Galynker I, editor. The suicidal crisis: clinical guide to the assessment of imminent suicide risk. 2nd. (NY): Oxford University Press; 2023. p. 256–C7P1329. doi: 10.1093/med/9780197582718.001.0001
   Google Scholar
• Cohen LJ, Imbastaro B, Peterkin D, et al. A suicide-specific diagnosis - The case for. Crisis. 2023;44(3):175–182. doi: 10.1027/0227-5910/a000911
   PubMedGoogle Scholar
• Ford JD, Gómez JM. The relationship of psychological trauma and dissociative and posttraumatic stress disorders to nonsuicidal self-injury and suicidality: a review. J Trauma Dissociation. 2015;16(3):232–271. doi: 10.1080/15299732.2015.989563 Epub 2015 Mar 11.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Boysan M, Guzel Ozdemir P, et al. Relationships between posttraumatic stress disorder (PTSD), dissociation, quality of life, hopelessness, and suicidal ideation among earthquake survivors. Psychiatry Res. 2015;228(3):598–605. doi: 10.1016/j.psychres.2015.05.045 Epub 2015 Jun 10.
   PubMed Web of Science ®Google Scholar
• Bertule M, Sebre SB, Kolesovs A. Childhood abuse experiences, depression and dissociation symptoms in relation to suicide attempts and suicidal ideation. J Trauma Dissociation. 2021;22(5):598–614. doi: 10.1080/15299732.2020.1869652 Epub 2021 Jan 11.
   PubMed Web of Science ®Google Scholar
• Yaseen ZS, Briggs J, Kopeykina I, et al. Distinctive emotional responses of clinicians to suicide-attempting patients–a comparative study. BMC Psychiatry. 2013;13(1):230.
   PubMedGoogle Scholar
• Galynker I, Yaseen Z, Briggs J. Assessing risk for imminent suicide. Psychiatr Ann. 2014;44(9):431–436. doi: 10.3928/00485713-20140908-07 Online 2014 Sept 8.
   Web of Science ®Google Scholar
• Imbastaro B, Lawrence OC, Goncearenco I, et al. Emotional response to suicidal patients in the assessment of imminent suicide risk. In: Galynker I, editor. The suicidal crisis: clinical guide to the assessment of imminent suicide risk. 2nd. (NY): Oxford University Press; 2023. p. 352–C8P222. doi: 10.1093/med/9780197582718.001.0001
   Google Scholar
• Bloch-Elkouby S, Zilcha-Mano S, Rogers ML, et al. Who are the patients who deny suicidal intent? Exploring patients’ characteristics associated with self-disclosure and denial of suicidal intent. Acta Psychiatr Scand. 2023;147(2):205–216. doi: 10.1111/acps.13511 Epub 2022 Dec 18.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Mokhtar R, Richards J, et al. The narrative-crisis model of suicide and its prediction of near-term suicide risk. Suicide Life Threat Behav. 2022;52(2):231–243. doi: 10.1111/sltb.12816. Epub 2021 Nov 11.
   PubMed Web of Science ®Google Scholar
• Bloch-Elkouby S, Barzilay S, Gorman BS, et al. The revised suicide crisis inventory (SCI-2): validation and assessment of prospective suicidal outcomes at one month follow-up. J Affect Disord. 2021;295:1280–1291. doi: 10.1016/j.jad.2021.08.048 Epub 2021 Aug 27.
   PubMed Web of Science ®Google Scholar
• Mitelman AM, Bafna A, Rogers ML, et al. Perceived clinical utility of the suicide crisis syndrome: a multisite pilot study. Psychological Services. 2023;20(Suppl 2):61–67. doi: 10.1037/ser0000779 Epub ahead of print 2023 Jun 1
   PubMedGoogle Scholar
• Karsen E, Cohen LJ, White B, et al. Impact of the abbreviated suicide crisis syndrome checklist on clinical decision making in the emergency department. J Clin Psychiatry. 2023;84(3):22m14655. doi: 10.4088/JCP.22m14655
   PubMed Web of Science ®Google Scholar
• Tucker RP, Michaels MS, Rogers ML, et al. Construct validity of a proposed new diagnostic entity: acute suicidal affective disturbance (ASAD). J Affect Disord. 2016;189:365–378. doi: 10.1016/j.jad.2015.07.049 Epub 2015 Sep 26.
   PubMed Web of Science ®Google Scholar
• Rogers ML, Chiurliza B, Hagan CR, et al. Acute suicidal affective disturbance: factorial structure and initial validation across psychiatric outpatient and inpatient samples. J Affect Disord. 2017;211:1–11. doi: 10.1016/j.jad.2016.12.057 Epub 2017 Jan 4.
   PubMed Web of Science ®Google Scholar
• Joiner TE, Simpson S, Rogers ML, et al. Whether called acute suicidal affective disturbance or suicide crisis syndrome, a suicide-specific diagnosis would enhance clinical care, increase patient safety, and mitigate clinician liability. J Psychiatr Pract. 2018;24(4):274–278. doi: 10.1097/PRA.0000000000000315
   PubMed Web of Science ®Google Scholar
• Rogers ML, Jeon ME, Zheng S, et al. Two sides of the same coin? Empirical examination of two proposed characterizations of acute suicidal crises: suicide crisis syndrome and acute suicidal affective disturbance. J Psychiatr Res. 2023;162:123–131. doi: 10.1016/j.jpsychires.2023.05.001. Epub 2023 May 3.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5^th edition (DSM-5™). Arlington (VA): American Psychiatric Association; 2013. doi: 10.1176/appi.books.9780890425596.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5^th edition-text revision (DSM-5-TR®). (WA) DC: American Psychiatric Association; 2022. doi: 10.1176/appi.books.9780890425787.
   Google Scholar
• Stone DM, Simon TR, Fowler KA, et al. Vital signs: trends in state suicide rates – United States, 1999-2016 and circumstances contributing to suicide – 27 States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(22):617–624.
   PubMed Web of Science ®Google Scholar
• Dome P, Rihmer Z, Gonda X. Suicide risk in bipolar disorder: A brief review. Medicina (Kaunas). 2019;55(8):403. doi: 10.3390/medicina55080403
   PubMed Web of Science ®Google Scholar
• Khoso AB, Noureen A, Un Nisa Z, et al. Prevalence of suicidal ideation and suicide attempts in individuals with psychosis and bipolar disorder in South Asia: systematic review and meta-analysis. BJPsych Open. 2023;9(6):e179. doi: 10.1192/bjo.2023.570
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68(10):1058–1064. doi: 10.1001/archgenpsychiatry.2011.113.
   PubMed Web of Science ®Google Scholar
• Fitzgerald C, Christensen RHB, Simons J, et al. Effectiveness of medical treatment for bipolar disorder regarding suicide, self-harm and psychiatric hospital admission: between- and within-individual study on Danish national data. Br J Psychiatry. 2022;221(5):692–700. doi: 10.1192/bjp.2022.54. Epub ahead of print 2022 Apr 22.
   Web of Science ®Google Scholar
• Hu FH, Jia YJ, Zhao DY, et al. Gender differences in suicide among patients with bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2023;339:601–614. doi: 10.1016/j.jad.2023.07.060. Epub 2023 Jul 17.
   PubMed Web of Science ®Google Scholar
• Murphy GE. Why women are less likely than men to commit suicide. Compr Psychiatry. 1998;39(4):165–175. doi: 10.1016/s0010-440x(98)90057-8
   PubMed Web of Science ®Google Scholar
• Bommersbach TJ, Rosenheck RA, Petrakis IL, et al. Why are women more likely to attempt suicide than men? Analysis of lifetime suicide attempts among US adults in a nationally representative sample. J Affect Disord. 2022;311:157–164. doi: 10.1016/j.jad.2022.05.096. Epub 2022 May 19.
   PubMed Web of Science ®Google Scholar
• Rabasco A, Arias S, Benz MB, et al. Longitudinal risk of suicide outcomes in people with severe mental illness following an emergency department visit and the effects of suicide prevention treatment. J Affect Disord. 2024;347:477–485. doi: 10.1016/j.jad.2023.12.019. Epub 2023 Dec 6.
   PubMed Web of Science ®Google Scholar
• Miola A, Tondo L, Pinna M, et al. Suicidal risk and protective factors in major affective disorders: a prospective cohort study of 4307 participants. J Affect Disord. 2023;338:189–198. doi: 10.1016/j.jad.2023.06.018. Epub 2023 Jun 8.
   PubMed Web of Science ®Google Scholar
• Janiri D, Moccia L, Montanari S, et al. Primary emotional systems, childhood trauma, and suicidal ideation in youths with bipolar disorders. Child Abuse Negl. 2023;146:106521. doi: 10.1016/j.chiabu.2023.106521. Epub 2023 Nov 5.
   PubMed Web of Science ®Google Scholar
• Anona K, Olaomi O, Udegbe E, et al. Co-occurrence of bipolar disorder and personality disorders in the United States: prevalence, suicidality, and the impact of substance abuse. J Affect Disord. 2024;345:1–7. doi: 10.1016/j.jad.2023.10.087. Epub 2023 Oct 15.
   PubMed Web of Science ®Google Scholar
• Teh WL, Liu J, Chandwani N, et al. Emotional urgency predicts bipolar symptoms, severity, and suicide attempt better than non-emotional impulsivity: a cross-sectional study. Frontiers In Psychology. 2023;14:1277655. doi: 10.3389/fpsyg.2023.1277655
   PubMed Web of Science ®Google Scholar
• Freitag S, Au JS, Liu DY, et al. Do bipolar disorder symptom profiles matter for suicide risk? A latent class approach to investigating differences in suicidal desire and acquired capability. Suicide & Life Threat Behav. 2023;54(1):24–37. doi: 10.1111/sltb.13013. Epub ahead of print 2023 Nov 8
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Akiskal KK, Haykal RF, et al. TEMPS-A: progress towards validation of a self-rated clinical version of the temperament evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord. 2005;85(1–2):3–16. doi: 10.1016/j.jad.2004.12.001
   PubMed Web of Science ®Google Scholar
• Ortiz A, Park Y, MacLean S, et al. A history of suicide attempt is associated with increased sympathetic activation in bipolar disorder. Can J Psychiatry. 2023;69(2):7067437231194334. doi: 10.1177/07067437231194334. Epub ahead of print 2023 Aug 16.
   Web of Science ®Google Scholar
• Zhong S, Chen P, Lai S, et al. Hippocampal dynamic functional connectivity, HPA axis activity, and personality trait in bipolar disorder with suicidal attempt. Neuroendocrinology. 2023;114(2):179–191. doi: 10.1159/000534033. Epub ahead of print 2023 Sep 20
   PubMed Web of Science ®Google Scholar
• Ambrosi E, Curtis KN, Goli P, et al. Resting-state functional connectivity of the anterior cingulate cortex among persons with mood disorders and suicidal behaviors. J Neuropsychiatry Clin Neurosci. 2023. appineuropsych20220203. doi: 10.1176/appi.neuropsych.20220203. Epub ahead of print 2023 Nov 20.
   Google Scholar
• Lewitzka U, Jabs B, Fülle M, et al. Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus treatment as usual (TAU) in patients with suicidal major depressive episode. BMC Psychiatry. 2015;15:117. doi: 10.1186/s12888-015-0499-5
   PubMedGoogle Scholar
• Coric V, Stock EG, Pultz J, et al. Sheehan suicidality tracking scale (sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry. 2009;6(1):26–31.
   PubMedGoogle Scholar
• Kashani P, Yousefian S, Amini A, et al. The effect of intravenous ketamine in suicidal ideation of emergency department patients. Emerg (Tehran). 2014;2(1):36–39.
   PubMedGoogle Scholar
• Burger J, Capobianco M, Lovern R, et al. A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting. Mil Med. 2016;181(10):1195–1199. doi: 10.7205/MILMED-D-15-00431
   PubMed Web of Science ®Google Scholar
• Fan W, Yang H, Sun Y, et al. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Oncotarget. 2017;8(2):2356–2360. doi: 10.18632/oncotarget.13743
   PubMedGoogle Scholar
• Bigman D, Kunaparaju S, Bobrin B. Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. BMJ Case Rep. 2017;2017:bcr2017222059. doi: 10.1136/bcr-2017-222059
   PubMedGoogle Scholar
• Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Depress Anxiety. 2020;37(3):224–233. doi: 10.1002/da.22975. Epub 2019 Nov 16.
   PubMed Web of Science ®Google Scholar
• Cong ML, Markwell S, Robertson L. Ketamine sedation of the pregnant patient with acute suicidal ideation during air medical transfer. Air Med J. 2020;39(2):143–144. doi: 10.1016/j.amj.2019.11.002. Epub 2019 Dec 4.
   PubMedGoogle Scholar
• Fu D-J, Ionescu DF, Li X, et al. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191. doi: 10.4088/JCP.19m13191
   PubMed Web of Science ®Google Scholar
• Ionescu DF, Fu D-J, Qiu X, et al. Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24(1):22–31. doi: 10.1093/ijnp/pyaa068
   PubMed Web of Science ®Google Scholar
• Maguire L, Bullard T, Papa L. Ketamine for acute suicidality in the emergency department: a systematic review. Am J Emerg Med. 2021;43:54–58. doi: 10.1016/j.ajem.2020.12.088. Epub 2021 Jan 14.
   PubMed Web of Science ®Google Scholar
• Diekamp B, Borentain S, Fu D-J, et al. Effect of concomitant benzodiazepine use on efficacy and safety of esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior: pooled randomized, controlled trials. Neuropsychiatr Dis Treat. 2021;17:2347–2357. doi: 10.2147/NDT.S314874
   PubMed Web of Science ®Google Scholar
• Canuso CM, Ionescu DF, Li X, et al. Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior. J Clin Psychopharmacol. 2021;41(5):516–524. doi: 10.1097/JCP.0000000000001465
   PubMed Web of Science ®Google Scholar
• Domany Y, McCullumsmith CB. Single, fixed-dose intranasal ketamine for alleviation of acute suicidal ideation. An emergency department, trans-diagnostic approach: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Arch Suicide Res. 2022;26(3):1250–1265. doi: 10.1080/13811118.2021.1878078 Epub 2021 Feb 14.
   PubMed Web of Science ®Google Scholar
• Voelker J, Sheehan JJ, Le HH, et al. US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior. J Comp Eff Res. 2022;11(5):319–328. doi: 10.2217/cer-2021-0226 Epub 2022 Jan 25
   PubMed Web of Science ®Google Scholar
• Shivanekar S, Gopalan P, Pizon A, et al. A pilot study of ketamine infusion after suicide attempt: new frontiers in treating acute suicidality in a real-world medical setting. Int J Environ Res Public Health. 2022;19(21):13792. doi: 10.3390/ijerph192113792
   PubMed Web of Science ®Google Scholar
• Turkoz I, Lopena O, Salvadore G, et al. Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE. CNS Spectr. 2023;28(4):482–488. doi: 10.1017/S1092852922000931 Epub ahead of print 2022 Jul 29
   Web of Science ®Google Scholar
• Zhdanava M, Teeple A, Pilon D, et al. Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. J Med Econ. 2023;26(1):691–700. doi: 10.1080/13696998.2023.2208993
   PubMed Web of Science ®Google Scholar
• Fu D-J, Zhang Q, Shi L, et al. Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality. BMC Psychiatry. 2023;23(1):587. doi: 10.1186/s12888-023-05017-y
   PubMed Web of Science ®Google Scholar
• Nierenberg A, Lavin P, Javitt DC, et al. NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. Int J Bipolar Disord. 2023;11(1):28. doi: 10.1186/s40345-023-00308-5
   PubMed Web of Science ®Google Scholar
• Alphs L, Fu D-J, Williamson D, et al. Suicide ideation and behavior assessment tool (SIBAT): evaluation of intra- and inter-rater reliability, validity, and mapping to Columbia classification algorithm of suicide assessment. Psychiatry Res. 2020;294:113495. doi: 10.1016/j.psychres.2020.113495 Epub 2020 Oct 3.
   PubMed Web of Science ®Google Scholar
• Guy W. Clinical Global Impressions. In: Guy W, editor. ECDEU assessment manual for psychopharmacology—revised. Rockville (MD): U.S. Department of Health, Education, and Welfare; Public Health Service, Alcohol; Drug Abuse, and Mental Health Administration; National Institute of Mental Health; Psychopharmacology Research Branch; Division of Extramural Research Programs; 1976. p. 218–222. OCLC 2344751. DHEW Publ No ADM 76–338.
   Google Scholar
• Wilkinson ST, Palamar JJ, Sanacora G. The rapidly shifting ketamine landscape in the US. JAMA Psychiatry. 2024;81(3):221–222. doi: 10.1001/jamapsychiatry.2023.4945 Epub ahead of print 2024 Jan 3.
   PubMed Web of Science ®Google Scholar
• Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand. 2001;104(3):163–172. doi: 10.1034/j.1600-0447.2001.00464.x
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11):1467–1473.
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Alphs L, Green AI, et al., International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82–91. doi: 10.1001/archpsyc.60.1.82 Errata corrige in: Arch Gen Psychiatry 2003;60(7):735.
   PubMed Web of Science ®Google Scholar
• Shen J, Tomar JS. Elevated brain glutamate levels in bipolar disorder and pyruvate carboxylase-mediated anaplerosis. Front Psychiatry. 2021;12:640977. doi: 10.3389/fpsyt.2021.640977
   PubMed Web of Science ®Google Scholar
• Lewis CP, Port JD, Blacker CJ, et al. Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation. Transl Psychiatry. 2020;10(1):119. doi: 10.1038/s41398-020-0792-z
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15(4):384–392. doi: 10.1038/mp.2009.47. Epub 2009 Jun 2.
   PubMed Web of Science ®Google Scholar
• Eastwood SL, Harrison PJ. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry. 2010;67(11):1010–1016. doi: 10.1016/j.biopsych.2009.12.004 Epub 2010 Jan 18.
   PubMed Web of Science ®Google Scholar
• Levinson AJ, Young LT, Fitzgerald PB, et al. Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation. J Clin Psychopharmacol. 2007;27(5):493–497. doi: 10.1097/jcp.0b013e31814ce524
   PubMed Web of Science ®Google Scholar
• Freed WJ, Dillon-Carter O, Kleinman JE. Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp Neurol. 1993;121(1):48–56. doi: 10.1006/exnr.1993.1070
   PubMed Web of Science ®Google Scholar
• Holemans S, De Paermentier F, Horton RW, et al. NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides. Brain Res. 1993;616(1–2):138–143. doi: 10.1016/0006-8993(93)90202-x
   PubMed Web of Science ®Google Scholar
• Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 1995;675(1–2):157–164. doi: 10.1016/0006-8993(95)00057-w
   PubMed Web of Science ®Google Scholar
• Noga JT, Hyde TM, Herman MM, et al. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. The Synapse. 1997;27(3):168–176. doi: 10.1002/(SICI)1098-2396(199711)27:3<168:AID-SYN2>3.0.CO;2-B
   PubMed Web of Science ®Google Scholar
• Sowa-Kućma M, Szewczyk B, Sadlik K, et al. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord. 2013;151(3):924–931. doi: 10.1016/j.jad.2013.08.009
   PubMed Web of Science ®Google Scholar
• Rafalo-Ulinska A, Piotrowska J, Kryczyk A, et al. Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. J Psychiatr Res. 2016;83:220–229. doi: 10.1016/j.jpsychires.2016.09.008 Epub 2016 Sep 13.
   PubMed Web of Science ®Google Scholar
• Zhao J, Verwer RWH, Gao SF, et al. Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide. J Psychiatr Res. 2018;102:261–274. doi: 10.1016/j.jpsychires.2018.04.020 Epub 2018 Apr 30.
   PubMed Web of Science ®Google Scholar
• Gray AL, Hyde TM, Deep-Soboslay A, et al. Sex differences in glutamate receptor gene expression in major depression and suicide. Mol Psychiatry. 2015;20(9):1057–1068. doi: 10.1038/mp.2015.91 Epub 2015 Jul 14. Erratum in: Mol Psychiatry. 2015;20(9):1139
   PubMed Web of Science ®Google Scholar
• Dean B, Duncan C, Gibbons A. Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses. J Affect Disord. 2019;244:80–84. doi: 10.1016/j.jad.2018.10.088 Epub 2018 Oct 6.
   PubMed Web of Science ®Google Scholar
• García-Gutiérrez MS, Navarro D, Torregrosa AB, et al. Alterations of BDNF, mGlur5, Homer1a, p11 and excitatory/inhibitory balance in corticolimbic brain regions of suicide decedents. J Affect Disord. 2023;339:366–376. doi: 10.1016/j.jad.2023.07.003 Epub 2023 Jul 16.
   PubMed Web of Science ®Google Scholar
• Panczyszyn-Trzewik P, Misztak P, Opoka W, et al. Oxidative stress responses and their alterations in the Nrf2-NMDA receptor pathway in the brain of suicide victims. J Physiol Pharmacol. 2023;74(3):335–346. doi: 10.26402/jpp.2023.3.08 Epub 2023 Aug 30.
   Web of Science ®Google Scholar
• Sani G, Margoni S, Brugnami A, et al. The Nrf2 pathway in depressive disorders: a systematic review of animal and human studies. Antioxidants (Basel). 2023;12(4):817. doi: 10.3390/antiox12040817
   PubMedGoogle Scholar
• Moxon-Emre I, Croarkin PE, Daskalakis ZJ, et al. Naa/Glu ratio associated with suicidal ideation in pilot sample of autistic youth and young adults. Brain Sci. 2022;12(6):785.
   PubMed Web of Science ®Google Scholar
• Dutton M, Boyes A, Can AT, et al. Hippocampal subfield volumes predict treatment response to oral ketamine in people with suicidality. J Psychiatr Res. 2024;169:192–200. doi: 10.1016/j.jpsychires.2023.11.040 Epub 2023 Nov 26.
   PubMed Web of Science ®Google Scholar
• Mann JJ, Currier D. Medication in suicide prevention insights from neurobiology of suicidal behavior. In: Dwivedi Y, editor. The neurobiological basis of suicide. Vol. Chapter 21. Boca Raton (FL): CRC Press/Taylor & Francis; 2012. p. 425–446. doi: 10.1201/b12215
   Google Scholar
• Aleksandrova LR, Phillips AG, Wang YT. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci. 2017;42(4):222–229. doi: 10.1503/jpn.160175
   PubMed Web of Science ®Google Scholar
• Suzuki A, Hara H, Kimura H. Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant. Neuropharmacology. 2023;222:109308. doi: 10.1016/j.neuropharm.2022.109308 Epub 2022 Oct 29.
   PubMed Web of Science ®Google Scholar
• Lazarevic V, Yang Y, Flais I, et al. Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol Psychiatry. 2021;26(12):7425–7435. doi: 10.1038/s41380-021-01246-3 Epub 2021 Aug 11.
   PubMed Web of Science ®Google Scholar
• Sleigh J, Harvey M, Voss L, et al. Ketamine – more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2–3):76–81. doi: 10.1016/j.tacc.2014.03.002
   Google Scholar
• Can AT, Mitchell JS, Dutton M, et al. Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine. Psychiatry Clin Neurosci. 2023;77(10):513–529. doi: 10.1111/pcn.13572 Epub 2023 Jul 5.
   PubMed Web of Science ®Google Scholar
• Ballard ED, Fields J, Farmer CA, et al. Clinical trials for rapid changes in suicidal ideation: lessons from ketamine. Suicide & Life Threat Behav. 2021;51(1):27–35. doi: 10.1111/sltb.12663
   PubMed Web of Science ®Google Scholar
• Kim JW, Suzuki K, Kavalali ET, et al. Ketamine: mechanisms and relevance to treatment of depression. Annu Rev Med. 2024;75:129–143. doi: 10.1146/annurev-med-051322-120608 Epub 2023 Sep 20.
   PubMed Web of Science ®Google Scholar
• Borsotto M, Cavarec L, Bouillot M, et al. PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder. Pharmacogenomics J. 2007;7(2):123–132. doi: 10.1038/sj.tpj.6500400 Epub 2006 May 30.
   PubMed Web of Science ®Google Scholar
• Judy JT, Seifuddin F, Pirooznia M, et al. Converging evidence for epistasis between ANK3 and potassium channel gene KCNQ2 in bipolar disorder. Front Genet. 2013;4:87. doi: 10.3389/fgene.2013.00087
   PubMedGoogle Scholar
• Xu S, Yao X, Li B, et al. Uncovering the underlying mechanisms of ketamine as a novel antidepressant. Front Pharmacol. 2022;12:740996. doi: 10.3389/fphar.2021.740996
   PubMed Web of Science ®Google Scholar
• Krystal JH, Kavalali ET, Monteggia LM. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology. 2024;49(1):41–50. doi: 10.1038/s41386-023-01629-w Epub 2023 Jul 24.
   PubMed Web of Science ®Google Scholar
• Casarotto PC, Girych M, Fred SM, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184(5):1299–313.e19. doi: 10.1016/j.cell.2021.01.034 Epub 2021 Feb 18.
   PubMed Web of Science ®Google Scholar
• Casarotto P, Umemori J, Castrén E. BDNF receptor TrkB as the mediator of the antidepressant drug action. Front Mol Neurosci. 2022;15:1032224. doi: 10.3389/fnmol.2022.1032224
   PubMed Web of Science ®Google Scholar
• Lewis V, Rurak G, Salmaso N, et al. An integrative view on the cell-type-specific mechanisms of ketamine’s antidepressant actions. Trends Neurosci. 2024;47(3):195–208. doi: 10.1016/j.tins.2023.12.004 Epub 2024 Jan 13
   PubMedGoogle Scholar
• Escelsior A, Sterlini B, Tardito S, et al. Evidence of alterations of beta-endorphin levels and mu-opioid receptor gene expression in bipolar disorder. Psychiatry Res. 2022;316:114787. doi: 10.1016/j.psychres.2022.114787
   PubMed Web of Science ®Google Scholar
• Erbay LG, Karlıdağ R, Oruç M, et al. Association of BDNF/TrkB and NGF/TrkA levels in postmortem brain with major depression and suicide. Psychiatry Danub. 2021;33(4):491–498. doi: 10.24869/psyd.2021.491
   PubMed Web of Science ®Google Scholar
• De Simone S, Bosco MA, La Russa R, et al. Suicide and neurotrophin factors: a systematic review of the correlation between BDNF and GDNF and self-killing. Healthcare. 2022;11(1):78. doi: 10.3390/healthcare11010078
   Web of Science ®Google Scholar
• Kohtala S, Rantamäki T. Rapid-acting antidepressants and the regulation of TrkB neurotrophic signalling-insights from ketamine, nitrous oxide, seizures and anaesthesia. Basic Clin Pharmacol Toxicol. 2021;129(2):95–103. doi: 10.1111/bcpt.13598 Epub 2021 May 24.
   PubMed Web of Science ®Google Scholar
• Zanos P, Brown KA, Georgiou P, et al. NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine. J Neurosci. 2023;43(6):1038–1050. doi: 10.1523/JNEUROSCI.1316-22.2022 Epub 2023 Jan 3.
   PubMed Web of Science ®Google Scholar
• Rogers ML, Bloch-Elkouby S, Galynker I. Differential disclosure of suicidal intent to clinicians versus researchers: associations with concurrent suicide crisis syndrome and prospective suicidal ideation and attempts. Psychiatry Res. 2022;312:114522. doi: 10.1016/j.psychres.2022.114522 Epub 2022 Mar 21.
   PubMed Web of Science ®Google Scholar
• Høyen KS, Solem S, Cohen LJ, et al. Non-disclosure of suicidal ideation in psychiatric inpatients: rates and correlates. Death Stud. 2022;46(8):1823–1831. doi: 10.1080/07481187.2021.1879317 Epub 2021 Feb 14.
   PubMed Web of Science ®Google Scholar
• Barzilay S, Assounga K, Veras J, et al. Assessment of near-term risk for suicide attempts using the suicide crisis inventory. J Affect Disord. 2020;276:183–190. doi: 10.1016/j.jad.2020.06.053 Epub 2020 Jul 15.
   PubMed Web of Science ®Google Scholar
• Calati R, Cohen LJ, Schuck A, et al. The modular assessment of risk for imminent suicide (MARIS): a validation study of a novel tool for suicide risk assessment. J Affect Disord. 2020;263:121–128. doi: 10.1016/j.jad.2019.12.001 Epub 2019 Dec 2.
   PubMed Web of Science ®Google Scholar
• Bafna A, Rogers ML, Galynker II. Predictive validity and symptom configuration of proposed diagnostic criteria for the suicide crisis syndrome: a replication study. J Psychiatr Res. 2022;156:228–235. doi: 10.1016/j.jpsychires.2022.10.027 Epub 2022 Oct 10.
   PubMed Web of Science ®Google Scholar
• Menon V, Bafna AR, Rogers ML, et al. Factor structure and validity of the revised suicide crisis inventory (SCI-2) among Indian adults. Asian J Psychiatr. 2022;73:103119. doi: 10.1016/j.ajp.2022.103119 Epub 2022 Apr 12.
   PubMed Web of Science ®Google Scholar
• Ohgami H, Terao T, Shiotsuki I, et al. Lithium levels in drinking water and risk of suicide. Br J Psychiatry. 2009;194(5):464–465. doi: 10.1192/bjp.bp.108.055798 discussion 446.
   PubMed Web of Science ®Google Scholar
• Kapusta ND, Mossaheb N, Etzersdorfer E, et al. Lithium in drinking water and suicide mortality. Br J Psychiatry. 2011;198(5):346–350. doi: 10.1192/bjp.bp.110.091041
   PubMed Web of Science ®Google Scholar
• Blüml V, Regier MD, Hlavin G, et al. Lithium in the public water supply and suicide mortality in Texas. J Psychiatr Res. 2013;47(3):407–411. doi: 10.1016/j.jpsychires.2012.12.002 Epub 2013 Jan 9
   PubMed Web of Science ®Google Scholar
• Helbich M, Leitner M, Kapusta ND. Geospatial examination of lithium in drinking water and suicide mortality. Int J Health Geogr. 2012;11:19. doi: 10.1186/1476-072X-11-19
   PubMed Web of Science ®Google Scholar
• Kabacs N, Memon A, Obinwa T, et al. Lithium in drinking water and suicide rates across the east of England. Br J Psychiatry. 2011;198(5):406–407. doi: 10.1192/bjp.bp.110.088617
   PubMed Web of Science ®Google Scholar
• Plöderl M, Naudet F. Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates. Int Clin Psychopharmacol. 2023;38(6):406–407. doi: 10.1097/YIC.0000000000000484 Epub 2023 Jun 20.
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Giménez-Palomo A, Radua J. Should we consider adding low-dose lithium to our diet to prevent cognitive decline and suicidality? Neurosci Biobehav Rev. 2023;153:105329. doi: 10.1016/j.neubiorev.2023.105329 Epub 2023 Jul 26.
   PubMed Web of Science ®Google Scholar
• Del Matto L, Muscas M, Murru A, et al. Lithium and suicide prevention in mood disorders and in the general population: a systematic review. Neurosci Biobehav Rev. 2020;116:142–153. doi: 10.1016/j.neubiorev.2020.06.017 Epub 2020 Jun 16.
   PubMed Web of Science ®Google Scholar
• Chiu CT, Scheuing L, Liu G, et al. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int J Neuropsychopharmacol. 2014;18(6):yu102.
   Web of Science ®Google Scholar
• Costemale-Lacoste JF, Guilloux JP, Gaillard R. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: a review of the literature. Encéphale. 2016;42(2):156–164. doi: 10.1016/j.encep.2016.02.003 Epub 2016 Mar 16.
   PubMed Web of Science ®Google Scholar
• Sani G, Napoletano F, Forte AM, et al. The wnt pathway in mood disorders. Curr Neuropharmacol. 2012;10(3):239–253. doi: 10.2174/157015912803217279
   PubMed Web of Science ®Google Scholar
• Price JB, Yates CG, Morath BA, et al. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. Transl Psychiatry. 2021;11(1):598. doi: 10.1038/s41398-021-01716-w
   PubMed Web of Science ®Google Scholar